Sign inCreate account

Report workspace tools

NCT04241380UNKNOWNanonymous

Anticoagulation Medicine in Surgical Repair for Total Anomalous Pulmonary Venous Connection: a Randomize Multi-centers Study

Sponsor

Source record

Guangdong Provincial People's Hospital

Phase

Source record

NA

Modality

AI-normalized

small molecule

Target

AI-normalized

Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Indication / condition

AI-normalized

Total Anomalous Pulmonary Venous Connection

Intervention

Source record

Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Source & freshness

Source record

NCT ID

NCT04241380

Original source

ClinicalTrials.gov

Source last updated

Feb 19, 2020

Ingested at

Jun 11, 2026

Internal sync

Jun 11, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT04241380

Title

Anticoagulation Medicine in Surgical Repair for Total Anomalous Pulmonary Venous Connection: a Randomize Multi-centers Study

Sponsor

Guangdong Provincial People's Hospital

Status

UNKNOWN

Phase

NA

Condition raw

Total Anomalous Pulmonary Venous Connection

Condition normalized

Total Anomalous Pulmonary Venous Connection

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Target normalized

Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Interventions

Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Public preview

Source record

Total anomalous pulmonary venous connection (TAPVC) is a complex congenital heart disease, requiring surgical repair. Pulmonary venous obstruction (PVO) is the major complication, with limited effective reinterventions and poor outcomes. This trial aims at investigating that postoperative anticoagulant management reduce the incidence of PVO.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Anticoagulation Medicine in Surgical Repair for Total Anomalous Pulmonary Venous Connection: a Randomize Multi-centers Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT04241380

Status

UNKNOWN

Phase

NA

Sponsor

Guangdong Provincial People's Hospital

Executive brief

Investment-Ready Snapshot

Total anomalous pulmonary venous connection (TAPVC) is a complex congenital heart disease, requiring surgical repair. Pulmonary venous obstruction (PVO) is the major complication, with limited effective reinterventions and poor outcomes. This trial aims at investigating that postoperative anticoagulant management reduce the incidence of PVO.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 19, 2020
Internal syncJun 11, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT04241380

Indication

Total Anomalous Pulmonary Venous Connection

Modality

small molecule

Target

Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Intervention

Anticoagulant Solutions, No anticoagulant solutions, Anticoagulant management

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.